News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALTANA Pharma (AAA) Selects Spotfire DecisionSite For Worldwide Use In Drug Discovery Research; Licensing Agreement Will Support ALTANA Pharma AG With Guided Analytics


10/19/2005 5:12:01 PM

Spotfire Inc., a market leader in visual data analytics applications for decision-making, today announced that ALTANA Pharma AG, a leading developer and manufacturer of innovative pharmaceutical products, has selected Spotfire DecisionSite(TM) analytic software worldwide for research, lead discovery and clinical safety. ALTANA Pharma AG has signed a global licensing agreement to use of DecisionSite across the research organization from target discovery through clinical safety in 4 global locations. The company is currently using DecisionSite in functional genomics and lead discovery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES